Remdesivir is active in vitro against tick-borne encephalitis virus and selects for resistance mutations in the viral RNA-dependent RNA polymerase - Kristina Nyström; Edward Trybala; Joanna Said; Anette Roth; Marianela Patzi Churqui; Ambjörn Kärmander; Tomas Cihlar; John P. Bilello; Tomas Bergström; Martin Lagging (Infectious Diseases, 2025)